Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms

Brain, Behavior, and Immunity

Volumn 26, Issue 2, 2012, Pages 346-352

  Aschbacher, K ^a   Epel, E ^a   Wolkowitz, O M ^a   Prather, A A ^a   Puterman, E ^a   Dhabhar, F S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Acute stress; Cytokine; Depressive symptoms; Interleukin 1 beta; Positive affect; Pro inflammatory; Reactivity

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIDEPRESSANT AGENT; INTERLEUKIN 1BETA; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ACUTE STRESS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHRONIC STRESS; CLINICAL ARTICLE; COGNITION; DEPRESSION; DRUG USE; EXERCISE TEST; FEMALE; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; MALE; POSITIVE AFFECT AND COGNITION; PRIORITY JOURNAL; TRIER SOCIAL STRESS TASK;

AFFECT; AGED; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 84855998031     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.10.010     Document Type: Article

References (47)

1. Altemus M., Rao B., Dhabhar F.S., Ding W., Granstein R.D. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 2001, 117:309-317.
2. Aschbacher K., Kemeny M.E. New directions in linking the dynamics of affective and stress-arousal systems. Brain Behav. Immun. 2011, 25:230-231.
3. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom. Med. 2004, 66:802-813.
4. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 1992, 573:318-320.
5. Breen E.C., Reynolds S.M., Cox C., Jacobson L.P., Magpantay L., Mulder C.B., Dibben O., Margolick J.B., Bream J.H., Sambrano E., Martinez-Maza O., Sinclair E., Borrow P., Landay A.L., Rinaldo C.R., Norris P.J. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin. Vaccine Immunol. 2011, 18:1229-1242.
6. Brydon L., Steptoe A. Stress-induced increases in interleukin-6 and fibrinogen predict ambulatory blood pressure at 3-year follow-up. J. Hypertens. 2005, 23:1001-1007.
7. Carroll J.E., Low C.A., Prather A.A., Cohen S., Fury J.M., Ross D.C., Marsland A.L. Negative affective responses to a speech task predict changes in interleukin (IL)-6. Brain Behav. Immun. 2011, 25:232-238.
8. Cohen S., Hamrick N. Stable individual differences in physiological response to stressors: implications for stress-elicited changes in immune related health. Brain Behav. Immun. 2003, 17:407-414.
9. Cuijpers P., Smit H. Excess mortality in depression: a meta-analysis of community studies. J. Affect. Disord. 2002, 72:227-236.
10. Cuijpers P., Smit F., Oostenbrink J., de Graaf R., ten Have M., Beekman A. Economic costs of minor depression: a population-based study. Acta Psychiatr. Scand. 2007, 115:229-236.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-57.
12. DellaGioia N., Hannestad J. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci. Biobehav. Rev. 2010, 34:130-143.
13. Dhabhar F.S., Burke H.M., Epel E.S., Mellon S.H., Rosser R., Reus V.I., Wolkowitz O.M. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J. Psychiatr. Res. 2009, 43:962-969.
14. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
15. Epel E.S., McEwen B.S., Ickovics J.R. Embodying psychological thriving: physical thriving in response to stress. J. Soc. Issues 1998, 54:301-322.
16. Epel, E., Daubenmier, J., Moskowitz, J.T., Folkman, S., Blackburn, E., 2009. Can meditation slow rate of cellular aging? Cognitive stress, mindfulness, and telomeres. Longevity, Regeneration, and Optimal Health: Integrating Eastern and Westen Perspectives 1172, 34-53.
17. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
18. Hayes A.F. Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun. Monogr. 2009, 76:408-420.
19. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 2007, 21:374-383.
20. Karsten J., Hartman C.A., Ormel J., Nolen W.A., Penninx B.W. Subthreshold depression based on functional impairment better defined by symptom severity than by number of DSM-IV symptoms. J. Affect. Disord. 2010, 123:230-237.
21. Kendler K.S., Karkowski L.M., Prescott C.A. Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J. Nerv. Ment. Dis. 1998, 186:661-669.
22. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
23. Luthar S.S., Cicchetti D., Becker B. The construct of resilience: a critical evaluation and guidelines for future work. Child Dev. 2000, 71:543-562.
24. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
25. Positive Affect and Immune Function 2007, Academic Press, San Diego, CA. A.L. Marsland, S. Pressman, S. Cohen (Eds.).
26. Matthews K.A., Katholi C.R., McCreath H., Whooley M.A., Williams D.R., Zhu S., Markovitz J.H. Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation 2004, 110:74-78.
27. Mendes W.B., Blascovich J., Major B., Seery M. Challenge and threat responses during downward and upward social comparisons. Eur. J. Soc. Psychol. 2001, 31:477-497.
28. Milaneschi Y., Corsi A.M., Penninx B.W., Bandinelli S., Guralnik J.M., Ferrucci L. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol. Psychiatry 2009, 65:973-978.
29. Miller G.E., Rohleder N., Stetler C., Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 2005, 67:679-687.
30. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
31. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., Maier S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 1998, 18:2239-2246.
32. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 2006, 163:1630-1633.
33. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., Burns C. The inventory of depressive symptomatology (Ids) - preliminary findings. Psychopharmacol. Bull. 1986, 22:985-990.
34. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., Trivedi M.H. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol. Med. 1996, 26:477-486.
35. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am. J. Psychiatry 2006, 163:1905-1917.
36. Sin N.L., Lyubomirsky S. Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis. J. Clin. Psychol. 2009, 65:467-487.
37. Sobel M.E. Asymptotic confidence intervals for indirect effects in structural equations models. Sociol. Methodol. 1982, 13:290-312.
38. Sobel M. The conditional level of confidence-intervals for the normal variance and applications. Commun. Stat. Theory 1989, 18:2813-2823.
39. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007, 21:901-912.
40. Steptoe A., Dockray S., Wardle J. Positive affect and psychobiological processes relevant to health. J. Pers. 2009, 77:1747-1776.
41. Stewart W.F., Ricci J.A., Chee E., Hahn S.R., Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 2003, 289:3135-3144.
42. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am. J. Psychiatry 2005, 162:175-177.
43. Tomaka J., Blascovich J., Kibler J., Ernst J.M. Cognitive and physiological antecedents of threat and challenge appraisal. J. Pers. Soc. Psychol. 1997, 73:63-72.
44. Unutzer J., Schoenbaum M., Katon W.J., Fan M.Y., Pincus H.A., Hogan D., Taylor J. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants. J. Am. Geriatr. Soc. 2009, 57:506-510.
45. van den Biggelaar A.H., Gussekloo J., de Craen A.J., Frolich M., Stek M.L., van der Mast R.C., Westendorp R.G. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp. Gerontol. 2007, 42:693-701.
46. Watson D., Clark L.A., Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54:1063-1070.
47. Wolkowitz O.M., Reus V.I., Mellon S.H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin. Neurosci. 2011, 13:25-39.